AdaptHealth
AHCO
137 hedge funds and large institutions have $1.88B invested in AdaptHealth in 2021 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 49 increasing their positions, 33 reducing their positions, and 45 closing their positions.
48% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 33
8% more call options, than puts
Call options by funds: $2.49M | Put options by funds: $2.31M
3.62% less ownership
Funds ownership: 56.72% → 53.1% (-3.6%)
6% less funds holding
Funds holding: 145 → 137 (-8)
18% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 45
21% less capital invested
Capital invested by funds: $2.39B → $1.88B (-$514M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$145M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$88.3M |
| 3 |
Morgan Stanley
New York
|
+$26.4M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
+$24.1M |
| 5 |
AC
Armistice Capital
New York
|
+$21M |
Top Sellers
AHCO Hedge Fund Activity: Q2 2021 in Review
137 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q2 2021, worth a combined $1.88B — down 21% from $2.39B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of AHCO and 37 opened new positions — a net loss of 8 holders — while 33 trimmed existing stakes and 49 added.
The largest buyer was Deerfield Management, adding an estimated $145M. The largest seller was Polar Capital Holdings, exiting entirely with an estimated $70.4M sold.
- 137 institutional investors held AdaptHealth (AHCO) as of Q2 2021, down from 145 in Q1 2021.
- Funds reported $1.88B of AdaptHealth stock for Q2 2021, down 21% quarter-over-quarter.
- 37 funds opened new AdaptHealth positions in Q2 2021 and 45 closed out, a net change of -8 holders.
- The largest AdaptHealth buyer in Q2 2021 was Deerfield Management, an estimated $145M added.
- The largest AdaptHealth seller in Q2 2021 was Polar Capital Holdings, an estimated $70.4M sold.
Based on aggregated 13F filings for Q2 2021.